new precautions about mood and behavior changes for patients taking Singulair (montelukast) and other leukotriene modifiers

You'll see new precautions about mood and behavior changes for patients taking Singulair (montelukast) and other leukotriene modifiers.

This is a surprise. We usually think of Singulair as benign.

But now some patients are reporting insomnia, agitation, anxiety, depression, and similar problems.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote